SETD6 controls the expression of estrogen-responsive genes and proliferation of breast carcinoma cells

Epigenetics

Volumn 9, Issue 7, 2014, Pages 942-950

  O'Neill, Daniel J ^a   Williamson, Stuart Charles ^a   Alkharaif, Dhuha ^a   Monteiro, Isabella Christina Mazzaro ^a   Goudreault, Marilyn ^b   Gaughan, Luke ^a   Robson, Craig N ^a   Gingras, Anne Claude ^b,c   Binda, Olivier ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b MOUNT SINAI HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cellular proliferation; Estrogen receptor; Lysine methyltransferase; SETD6

Indexed keywords

ALPHA TUBULIN; CELL NUCLEUS RECEPTOR; CELL PROTEIN; CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1A; DNA BINDING PROTEIN; ESTROGEN RECEPTOR ALPHA; GREEN FLUORESCENT PROTEIN; HISTONE DEACETYLASE 1; HISTONE LYSINE METHYLTRANSFERASE; INTESTINAL TREFOIL FACTOR; METASTASIS ASSOCIATED PROTEIN 2; NUCLEAR RECEPTOR COREPRESSOR; PROGESTERONE RECEPTOR; PROTEIN P53; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR GAL4; TRANSCRIPTION FACTOR SIN3A; UNCLASSIFIED DRUG; VASCULOTROPIN A; YELLOW FLUORESCENT PROTEIN; CHROMATIN; ESTROGEN; ESTROGEN RECEPTOR ALPHA, HUMAN; HDAC1 PROTEIN, HUMAN; HISTONE DEACETYLASE; MTA2 PROTEIN, HUMAN; NUCLEAR PROTEIN; PROTEIN METHYLTRANSFERASE; REPRESSOR PROTEIN; SETD6 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; BINDING AFFINITY; BREAST CARCINOMA; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ESTROGEN RESPONSIVE GENE; FLOW CYTOMETRY; GENE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INTRACELLULAR SIGNALING; LUCIFERASE ASSAY; MASS SPECTROMETRY; MRNA EXPRESSION ASSAY; POSTTRANSCRIPTIONAL GENE SILENCING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; BREAST TUMOR; CELL CYCLE; CHROMATIN; FEMALE; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATIN; ESTROGEN RECEPTOR ALPHA; ESTROGENS; FEMALE; HISTONE DEACETYLASE 1; HISTONE DEACETYLASES; HUMANS; NUCLEAR PROTEINS; PROTEIN METHYLTRANSFERASES; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84903693499     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.28864     Document Type: Article

References (53)

1. Anderson JD, Lowary PT, Widom J. Effects of histone acetylation on the equilibrium accessibility of nucleosomal DNA target sites. J Mol Biol 2001; 307:977-985.PMID:11286549; http://dx.doi.org/10.1006/jmbi.2001.4528
2. Hong L, Schroth GP, Matthews HR, Yau P, Bradbury EM. Studies of the DNA binding properties of histone H4 amino terminus. Thermal denaturation studies reveal that acetylation markedly reduces the binding constant of the H4 "tail" to DNA. J Biol Chem 1993; 268:305-314.PMID:8416938
3. Lee DY, Hayes JJ, Pruss D, Wolffe AP. A positive role for histone acetylation in transcription factor access to nucleosomal DNA. Cell 1993; 72:73-84. PMID:8422685; http://dx.doi.org/10.1016/0092-8674(93)90051-Q
4. Musselman CA, Lalonde M-È, Côté J, Kutateladze TG. Perceiving the epigenetic landscape through histone readers. Nat Struct Mol Biol 2012; 19:1218-1227.P M I D: 2 3 211769; http://dx.doi.org/10.1038/nsmb.2436
5. Barski A, Cuddapah S, Cui K, Roh T-Y, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K. High-resolution profiling of histone methylations in the human genome. Cell 2007; 129:823-837.PMID:17512414; http://dx.doi.org/10.1016/j.cell.2007.05.009
6. Allfrey VG, Faulkner R, Mirsky AE. Acetylation and Methylation of Histones and their Possible Role in the Regulation of RNA Synthesis. Proc Natl Acad Sci USA 1964; 51:786-794.PMID:14172992; http://dx.doi.org/10.1073/pnas.51.5.786
7. Murray K. The Occurrence of ε-N-Methyl Lysine in Histones. Biochemistry 1964; 3:10-315.PMID:14114491; http://dx.doi.org/10.1021/bi00889a003
8. Rea S, Eisenhaber F, O'Carroll D, Strahl BD, Sun Z-W, Schmid M, Opravil S, Mechtler K, Ponting CP, Allis CD, et al. Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature 2000; 406:593-599.PMID:10949293; http://dx.doi.org/10.1038/35020506
9. Clarke SG. Protein methylation at the surface and buried deep: thinking outside the histone box. Trends Biochem Sci 2013; 38:243-252. PMID:23490039; http://dx.doi.org/10.1016/j.tibs.2013.02.004
10. Cloutier P, Lavallée-Adam M, Faubert D, Blanchette M, Coulombe B. A newly uncovered group of distantly related lysine methyltransferases preferentially interact with molecular chaperones to regulate their activity. PLoS Genet 2013; 9:e1003210.PMID:23349634; http://dx.doi.org/10.1371/jour-nal.pgen.1003210
11. Schneider R, Bannister AJ, Kouzarides T. Unsafe SETs: histone lysine methyltransferases and cancer. Trends Biochem Sci 2002; 27:396-402.PMID:12151224; http://dx.doi.org/10.1016/S0968-0004(02)02141-2
12. Albert M, Helin K. Histone methyltransferases in cancer. Semin Cell Dev Biol 2010; 21:209-220.PMID:19892027; http://dx.doi.org/10.1016/j.semcdb.2009.10.007
13. Rahman N. Mechanisms predisposing to childhood overgrowth and cancer. Curr Opin Genet Dev 2005; 15:227-233. PMID: 15917196; http://dx.doi.org/10.1016/j.gde.2005.04.007
14. Nimura K, Ura K, Shiratori H, Ikawa M, Okabe M, Schwartz RJ, Kaneda Y. A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome. Nature 2009; 460:287-291. PMID:19483677; http://dx.doi.org/10.1038/nature08086
15. Ryu H, Lee J, Hagerty SW, Soh BY, McAlpin SE, Cormier KA, Smith KM, Ferrante RJ. ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease. Proc Natl Acad Sci USA 2006; 103:19176-19181.PMID:17142323; http://dx.doi.org/10.1073/pnas.0606373103
16. Binda O, Sevilla A, LeRoy G, Lemischka IR, Garcia BA, Richard S. SETD6 monomethylates H2AZ on lysine 7 and is required for the maintenance of embryonic stem cell self-renewal. Epigenetics 2013; 8:177-183.PMID:23324626; http://dx.doi.org/10.4161/epi.23416
17. Levy D, Kuo AJ, Chang Y, Schaefer U, Kitson C, Cheung P, Espejo A, Zee BM, Liu CL, Tangsombatvisit S, et al. Lysine methylation of the NF-κB subunit RelA by SETD6 couples activity of the histone methyltransferase GLP at chromatin to tonic repression of NF-κB signaling. Nat Immunol 2011; 12: 29-36.PMID: 21131967; http://dx.doi.org/10.1038/ni.1968
18. Holst F, Stahl PR, Ruiz C, Hellwinkel O, Jehan Z, Wendland M, Lebeau A, Terracciano L, Al-Kuraya K, Jänicke F, et al. Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer. Nat Genet 2007; 39:655-660.PMID:17417639; http://dx.doi.org/10.1038/ng2006
19. Fuqua SA, Chamness GC, McGuire WL. Estrogen receptor mutations in breast cancer. J Cell Biochem 1993; 51:135-139.PMID:8440747; http://dx.doi.org/10.1002/jcb.240510204
20. Metzger D, White JH, Chambon P. The human oestrogen receptor functions in yeast. Nature 1988; 33 4:31-36.PMID:3290686; http://dx.doi.org/10.1038/334031a0
21. Green S, Walter P, Kumar V, Krust A, Bornert JM, Argos P, Chambon P. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 1986; 320:134-139.PMID:3754034; http://dx.doi.org/10.1038/320134a0
22. Lippman M, Bolan G, Huff K. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 1976; 36:4595-601.PMID:1000504
23. Kim W, Bennett EJ, Huttlin EL, Guo A, Li J, Possemato A, Sowa ME, Rad R, Rush J, Comb MJ, et al. Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell 2011; 44: 325-340.PMID: 21906983; http://dx.doi.org/10.1016/j.molcel.2011.08.025
24. Kean MJ, Ceccarelli DF, Goudreault M, Sanches M, Tate S, Larsen B, Gibson LC, Derry WB, Scott IC, Pelletier L, et al. Structure-function analysis of core STRIPAK Proteins: a signaling complex implicated in Golgi polarization. J Biol Chem 2011; 286:25065-25075.PMID: 21561862; http://dx.doi.org/10.1074/jbc.M110.214486
25. Kean MJ, Couzens AL, Gingras A-C. Mass spectrometry approaches to study mammalian kinase and phosphatase associated proteins. Methods 2012; 57:400-408.PMID:22710030; http://dx.doi.org/10.1016/j.ymeth.2012.06.002
26. Zhang Y, Ng HH, Erdjument-Bromage H, Tempst P, Bird A, Reinberg D. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev 1999; 13:1924-1935. PMID:10444591; http://dx.doi.org/10.1101/gad.13.15.1924
27. Okada M, Takezawa S, Mezaki Y, Yamaoka I, Takada I, Kitagawa H, Kato S. Switching of chromatin-remodelling complexes for oestrogen receptor-alpha. EMBO Rep 2008; 9:563-568.PMID:18451880; http://dx.doi.org/10.1038/embor.2008.55
28. Denslow SA, Wade PA. The human Mi-2/NuRD complex and gene regulation. Oncogene 2007; 26:5433-5438.PMID:17694084; http://dx.doi.org/10.1038/sj.onc.1210611
29. Binda O, Roy J-S, Branton PE. RBP1 family proteins exhibit SUMOylation-dependent transcriptional repression and induce cell growth inhibition reminiscent of senescence. Mol Cell Biol 2006; 26:1917-1931.PMID:16479010; http://dx.doi.org/10.1128/MCB.26.5.1917-1931.2006
30. Deblois G, Giguère V. Oestrogen-related receptors in breast cancer: control of cellular metabolism and beyond. Nat Rev Cancer 2013; 13:27-36.PMID:23192231; http://dx.doi.org/10.1038/nrc3396
31. Yao Y-L, Yang W-M. The metastasis-associated proteins 1 and 2 form distinct protein complexes with histone deacetylase activity. J Biol Chem 2003; 278:42560-42568.PMID:12920132; http://dx.doi.org/10.1074/jbc.M302955200
32. Cui Y, Niu A, Pestell R, Kumar R, Curran EM, Liu Y, Fuqua SA. Metastasis-associated protein 2 is a repressor of estrogen receptor alpha whose overexpression leads to estrogen-independent growth of human breast cancer cells. Mol Endocrinol 2006; 20:2020-2035.PMID:16645043; http://dx.doi.org/10.1210/me.2005-0063
33. Liu X-F, Bagchi MK. Recruitment of distinct chromatin-modifying complexes by tamoxifencomplexed estrogen receptor at natural target gene promoters in vivo. J Biol Chem 2004; 279:15050-15058.PMID:14722073; http://dx.doi.org/10.1074/jbc.M311932200
34. Hatchell EC, Colley SM, Beveridge DJ, Epis MR, Stuart LM, Giles KM, Redfern AD, Miles LE, Barker A, MacDonald LM, et al. SLIRP, a small SRA binding protein, is a nuclear receptor corepressor. Mol Cell 2006; 22:657-668. PMID:16762838; http://dx.doi.org/10.1016/j.molcel.2006.05.024
35. Wang Z, Zang C, Cui K, Schones DE, Barski A, Peng W, Zhao K. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell 2009; 138:1019-1031. PMID: 19698979; http://dx.doi.org/10.1016/j.cell.2009.06.049
36. Purcell DJ, Jeong K W, Bittencourt D, Gerke DS, Stallcup MR. A distinct mechanism for coactivator versus corepressor function by histone methyltransferase G9a in transcriptional regulation. J Biol Chem 2011; 286:41963-41971.PMID:21984853; http://dx.doi.org/10.1074/jbc.M111.298463
37. Stelzl U, Worm U, Lalowski M, Haenig C, Brembeck FH, Goehler H, Stroedicke M, Zenkner M, Schoenherr A, Koeppen S, et al. A human protein-protein interaction network: a resource for annotating the proteome. Cell 2005; 122:957-968.PMID:16169070; http://dx.doi.org/10.1016/j.cell.2005.08.029
38. Brady ME, Ozanne DM, Gaughan L, Waite I, Cook S, Neal DE, Robson CN. Tip60 is a nuclear hormone receptor coactivator. J Biol Chem 1999; 274:17599-17604.PMID:10364196; http://dx.doi.org/10.1074/jbc.274.25.17599
39. Jeong KW, Kim K, Situ AJ, Ulmer TS, An W, Stallcup MR. Recognition of enhancer element-specific histone methylation by TIP60 in transcriptional activation. Nat Struct Mol Biol 2011; 18:1358-1365.PMID:22081016; http://dx.doi.org/10.1038/nsmb.2153
40. Dou Y, Milne TA, Tackett AJ, Smith ER, Fukuda A, Wysocka J, Allis CD, Chait BT, Hess JL, Roeder RG. Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF. Cell 2005; 121:873-885.PMID:15960975; http://dx.doi.org/10.1016/j.cell.2005.04.031
41. Yanagisawa J, Kitagawa H, Yanagida M, Wada O, Ogawa S, Nakagomi M, Oishi H, Yamamoto Y, Nagasawa H, McMahon SB, et al. Nuclear receptor function requires a TFTC-type histone acetyl transferase complex. Mol Cell 2002; 9:553-562.PMID:11931763; http://dx.doi.org/10.1016/S1097-2765(02)00478-1
42. Cheng ASL, Jin VX, Fan M, Smith LT, Liyanarachchi S, Yan PS, Leu YW, Chan MW, Plass C, Nephew KP, et al. Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters. Mol Cell 2006; 21:393-404.PMID:16455494; http://dx.doi.org/10.1016/j.molcel.2005.12.016
43. Chen W-Y, Zhang J, Geng H, Du Z, Nakadai T, Roeder RGA. A TAF4 coactivator function for E proteins that involves enhanced TFIID binding. Genes Dev 2013; 27:1596-1609.PMID:23873942; http://dx.doi.org/10.1101/gad.216192.113
44. Kazantseva J, Kivil A, Tints K, Kazantseva A, Neuman T, Palm K. Alternative splicing targeting the hTAF4-TAFH domain of TAF4 represses proliferation and accelerates chondrogenic differentiation of human mesenchymal stem cells. PLoS One 2013; 8: e74799.PMID:24098348; http://dx.doi.org/10.1371/journal.pone.0074799
45. McMahon SB, Van Buskirk HA, Dugan KA, Copeland TD, Cole MD. The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell 1998; 94:363-374.PMID:9708738; http://dx.doi.org/10.1016/S0092_8674(00)81479-8
46. Deleu L, Shellard S, Alevizopoulos K, Amati B, Land H. Recruitment of TRRAP required for oncogenic transformation by E1A. Oncogene 2001; 20:8270-8275.PMID: 11781841; http://dx.doi.org/10.1038/sj.onc.1205159
47. Murr R, Vaissière T, Sawan C, Shukla V, Herceg Z. Orchestration of chromatin-based processes: mind the TRRAP. Oncogene 2007; 26:5358-5372.PMID:17694078; http://dx.doi.org/10.1038/sj.onc.1210605
48. Herceg Z, Hulla W, Gell D, Cuenin C, Lleonart M, Jackson S, Wang ZQ. Disruption of Trrap causes early embryonic lethality and defects in cell cycle progression. Nat Genet 2001; 29:206-211.PMID:11544477; http://dx.doi.org/10.1038/ng725
49. Toyoshima M, Howie HL, Imakura M, Walsh RM, Annis JE, Chang AN, Frazier J, Chau BN, Loboda A, Linsley PS, et al. Functional genomics identifies therapeutic targets for MYC-driven cancer. Proc Natl Acad Sci USA 2012; 109:9545-9550. PMID: 22623531; http://dx.doi.org/10.1073/pnas.1121119109
50. Richter M. Setd6 a Novel Histone Lysine Monomethyltransferase. Lightning Source Incorporated, 2009.
51. Doyon Y, Cayrou C, Ullah M, Landry A-J, Côté V, Selleck W, Lane WS, Tan S, Yang XJ, Côté J. ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation. Mol Cell 2006; 21:51-64.PMID:16387653; http://dx.doi.org/10.1016/j. molcel.2005.12.007
52. Auger A, Galarneau L, Altaf M, Nourani A, Doyon Y, Utley RT, Cronier D, Allard S, Côté J. Eaf1 is the platform for NuA4 molecular assembly that evolutionarily links chromatin acetylation to ATP-dependent exchange of histone H2A variants. Mol Cell Biol 2008; 28:2257-2270.PMID:18212047; http://dx.doi.org/10.1128/MCB.01755-07
53. Binda O, Nassif C, Branton PE. SIRT1 negatively regulates HDAC1-dependent transcriptional repression by the RBP1 family of proteins. Oncogene 2008; 27:3384-3392.PMID:18193082; http://dx.doi.org/10.1038/sj.onc.1211014